Works matching IS 1934662X AND DT 2022 AND VI 130 AND IP 4


Results: 9
    1

    Issue Information.

    Published in:
    Cancer Cytopathology, 2022, v. 130, n. 4, p. 239, doi. 10.1002/cncy.22575
    Publication type:
    Article
    2
    3

    Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine‐needle aspirates: A quality‐assurance metric for evaluating diagnostic performance in a cytopathology laboratory.

    Published in:
    Cancer Cytopathology, 2022, v. 130, n. 4, p. 259, doi. 10.1002/cncy.22542
    By:
    • Gokozan, Hamza N.;
    • Dilcher, Thomas L.;
    • Alperstein, Susan A.;
    • Qiu, Yuqing;
    • Mostyka, Maria;
    • Scognamiglio, Theresa;
    • Solomon, James P.;
    • Song, Wei;
    • Rennert, Hanna;
    • Beg, Shaham;
    • Stern, Evan;
    • Goyal, Abha;
    • Siddiqui, Momin T.;
    • Heymann, Jonas J.
    Publication type:
    Article
    4
    5
    7
    8
    9